Answers are grounded in this paper and cite their sources.
Astrocytomas or brain gliomas are the most common type of intraaxial tumors. In Mexico they account for 2.3% of primary central nervous system neoplasms. During the management of these tumors it is frequently a need to determine which cases are candidates to radiotherapy, chemotherapy or both. Genetic markers for the vast majority of tumors exist, some are useful to guide their treatment. Description of the available markers that help reach and guide the treatment these patients is made. DNA methylation promoter in a CpG island methylator phenotype was found in glioblastomas. Magnetic resonance spectroscopic imaging with hyperpolarized pyruvate highlight the difference between tumor’s persistence and radiotherapy effects, as well as the immediate response to temozolamide. The use of these techniques is proposed to optimize the therapy for these patients.
No takes yet. Share an insight, caveat, or question.
Arroyo-Mayorga et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: